NOS2 and neoplasm: Drug administration subverted the phenotype of tumor-infiltrating CD11b+ Ly6Chi Ly6G− myeloid cells, favoring NOS2/ROS secretion and expression of pro-inflammatory genes characteristic of M1 polarization.